Best GLP-1 Providers: The Top Online GLP-1 Programs Ranked (2026)
Affiliate disclosure: We may earn a commission from links on this page at no cost to you. Rankings are editorially independent. Full policy
If you are searching for the best GLP-1 providers, you are usually trying to solve one of three problems:
- You want brand-name GLP-1s (Wegovy, Zepbound) and help with insurance paperwork
- You want an online program with real coaching and clinician follow-ups
- You want a predictable cash-pay option and need to understand the tradeoffs
After comparing programs on price transparency, medical oversight, insurance support, cancellation policies, and medication access, here are the top picks for 2026:
If you need:
Insurance + done-for-you paperwork
Ro Body Program
Full concierge handles prior auth, appeals, coverage disputes
If you need:
Coaching + behavior change focus
WeightWatchers Clinic
Points system + dietitian access + 21% avg weight loss at 12 months
If you need:
Structured year-long metabolic reset
Calibrate
$199/mo, biweekly coaching, 10% weight loss guarantee
If you need:
Budget cash-pay (brand-name)
Sesame or WeightWatchers
WW has $199/mo Wegovy deal through March 2026
If you need:
Budget cash-pay (compounded)
MEDVi or ShedRx
$179-299/mo all-inclusive, month-to-month
Semaglutide vs tirzepatide quick take: The SURMOUNT-5 trial (May 2025) showed tirzepatide produced 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks. Tirzepatide also had fewer GI side effects leading to discontinuation. But semaglutide has the longer safety track record and is now available as a daily pill (FDA approved December 22, 2025).
Medical note: This content is for educational comparison only—not medical advice. GLP-1 medications require a prescription and ongoing monitoring. Always consult a licensed clinician. Read full disclaimer
Comparison Table: Best GLP-1 Providers (2026)
How to read this: Pick the row that matches how you plan to pay (insurance vs cash), then verify current pricing and availability in your state before signing up.
| Rank | Provider | Best For | Medications | Program Cost | Medication Cost | Insurance | Cancellation | Link |
|---|---|---|---|---|---|---|---|---|
| 1 | Ro Body Program | Insurance navigation | Brand-name only (Wegovy, Zepbound, Ozempic) | $45 first mo, then $145/mo | Copay w/ insurance; Cash: $349-499/mo | 48-hour rule | Visit | |
| 2 | WeightWatchers Clinic | Coaching + Points system | Brand-name only | $25/mo × 3, then $74/mo | Insurance varies; Cash: $199-349+/mo | Commitment required | Visit | |
| 3 | Calibrate | Structured year-long program | Brand-name via insurance | $199/mo (3-mo minimum) | ~$25/mo after deductible | 72-hour window | Visit | |
| 4 | Form Health | Clinician + dietitian care | FDA-approved obesity meds | $299/mo self-pay | Separate | Clear terms | Visit | |
| 5 | PlushCare | Primary care approach | Brand-name GLP-1s | Visit/membership varies | Separate | Clear terms | Visit | |
| 6 | MEDVi | Budget cash-pay | Compounded semaglutide & tirzepatide | Included | $179-299/mo (sema), $279-499/mo (tirz) | Month-to-month | Visit | |
| 7 | ShedRx | Flexibility (compounded + brand) | Both options | Included | Compounded: $199-499/mo | 72-hr rule, 2-mo min | Visit | |
| 8 | Hims/Hers | Familiar brand + app | Compounded sema + oral kits | Included | $199/mo (6-mo upfront) | Plan-dependent | Visit | |
| 9 | Sesame | Low-friction transparent pricing | Brand-name prescriptions | ~$99/mo | Separate | 48-hour rule | Visit | |
| 10 | Found | Community + multiple med options | Multiple (GLP-1s + alternatives) | ~$129/mo self-pay | Separate | Strict terms | Visit |
Important: Pricing changes frequently. Use this table to narrow to 2-3 options, then verify on each provider's site.
What I checked (December 27-28, 2025):
- Pricing pages: membership fees, what's included vs separate
- Promo terms: end dates, dose restrictions, eligibility limits
- Cancellation language: auto-renewal, refund windows, notice requirements
- State availability: when providers clearly disclose it
What I did NOT use for rankings:
- - Unverified star ratings scraped from random sites
- - Made-up review counts
- - Commission size
If a provider will not clearly disclose pricing, cancellation rules, and medication pathway, that is a negative ranking factor.
The FDA approved oral semaglutide (Wegovy 25mg pill) on December 22, 2025. Launch is expected early January 2026.
| How it works | Daily pill instead of weekly injection |
| Weight loss | ~16.6% average over 64 weeks in trials |
| Starter pricing | ~$149/mo through certain savings programs |
| The catch | Must take on empty stomach, wait 30 min before eating |
This matters for needle-averse patients. But injectable versions still show slightly better results and do not require the morning fasting ritual.
A legitimate online GLP-1 program includes:
- A medical intake (questionnaire + sometimes photos/weight)
- A consultation with a licensed clinician (async, video, or phone depending on state)
- A prescriber who evaluates whether medication is appropriate for you
- Follow-ups and dose adjustments
- Insurance navigation OR clear cash-pay pricing
- Medication fulfillment through a licensed pharmacy
A "GLP-1 provider" is NOT:
- - A site selling "research peptides" or "not for human consumption" products
- - A checkout page where you buy medication with no real medical evaluation
- - A "miracle weight loss" ad hiding who prescribes and where medication comes from
If a site will not tell you who prescribes, what pharmacy fulfills, and what the cancellation policy is—walk away.
Brand-Name vs Compounded GLP-1s: The 2026 Reality
This is the most important distinction in the market right now. You need to understand it before choosing a provider.
Examples: Wegovy (semaglutide), Zepbound (tirzepatide), Ozempic (off-label)
FDA-approved products manufactured by Novo Nordisk or Eli Lilly with rigorous quality controls.
Pros:
- + Known manufacturing quality and consistency
- + Standard dosing pens with clear labeling
- + Established safety data from large clinical trials
Cons:
- - Cash price: $800-1,500/month without discounts
- - Insurance coverage inconsistent
- - Local supply constraints still happen
Custom preparations of semaglutide or tirzepatide made by compounding pharmacies. Same active ingredients but not FDA-approved products.
Regulatory status (Dec 2025): FDA removed both from shortage list. Compounding under shortage exception is no longer permitted, though lawsuits have created legal ambiguity.
The FDA has reported over 1,000 adverse events linked to compounded GLP-1 formulations as of mid-2025.
If considering compounded GLP-1s, verify these before paying:
- What is the exact active ingredient form?
- Which pharmacy fulfills it? Is it a 503B outsourcing facility (stricter regulation) or 503A state-licensed pharmacy?
- Does the pharmacy conduct third-party potency and sterility testing?
- Will you receive a Medication Guide and counseling about risks?
- What are the dose, titration schedule, and administration instructions?
- What is the refund/cancellation policy if you need to stop?
Our take: Brand-name is safer if you can afford it or have insurance. Compounded is a reasonable alternative for cash-pay patients using reputable providers with verified pharmacy partnerships—but the regulatory landscape is shifting.
I score programs on six factors. This is not complicated—it is what matters when $200-$1,500/month is on the line.
| Factor | Weight | What I Look For |
|---|---|---|
| Price Transparency | 25% | All costs upfront? Membership, visits, meds, shipping, labs? |
| Clinical Oversight | 20% | Licensed clinicians? Easy follow-up? Labs when appropriate? |
| Medication Access | 20% | Brand-name and/or compounded? Insurance pathways? Clear pharmacy? |
| Insurance Support | 15% | Prior auth help, appeals, documentation, navigation? |
| Cancellation & Refunds | 10% | Clear steps? Clear timing? No trap subscriptions? |
| User Experience | 10% | Support response, refill cadence, app quality? |
What I do not consider: Hype, fake urgency, or commission size.
Full Reviews: The Best Online GLP-1 Programs
Best for: People pursuing brand-name GLP-1s who want help with insurance paperwork without chasing forms themselves.
Ro built its program around a real problem: getting insurance to cover GLP-1 medications is a bureaucratic nightmare. Their insurance concierge handles prior authorizations, appeals, and coverage disputes on your behalf. If your insurance denies coverage, they fight for you or present cash-pay alternatives.
The membership includes provider consultations, metabolic labs (through Quest, included free), unlimited messaging, monthly check-ins, and a tracking app. Medications are billed separately.
Verified Pricing (December 2025)
- Membership (first month): $45
- Membership (ongoing): $145/month
- Medication with insurance: Your copay
- Medication cash-pay (starter doses): $199/mo first 2 months, then $349/mo
- Labs: Included (Quest locations)
Cancellation: Month-to-month. Cancel at least 48 hours before billing date.
Who should skip Ro:
- - If you only want a one-off prescription with no ongoing program—you are paying for support you will not use
- - If you want compounded medications, Ro is not the right fit
- - If you are extremely price-sensitive on membership fees, $145/mo adds up
Best for: People who want GLP-1 access AND a proven coaching framework for long-term results.
WeightWatchers spent decades building behavior change tools—the Points system, recipes, community workshops, dietitian access. Their Clinic bolts medical weight management onto that foundation.
In a study of 3,250 WW Clinic patients on GLP-1s, average weight loss was 21% of body weight at 12 months. They have also struck a deal with Novo Nordisk to offer Wegovy at $199/month for starter doses (through March 2026).
Verified Pricing (December 2025)
- Membership (first 3 months, 12-mo commitment): $25/month
- Membership (ongoing): $74/month
- Wegovy cash-pay (starter doses, through 3/31/26): $199/month
- Wegovy cash-pay (maintenance): $349+/month
Cancellation: Commitment-based. You can cancel anytime but pay through the end of your term.
Who should skip WW Clinic:
- - If you do not want a 12-month commitment
- - If you want compounded medications (they only prescribe FDA-approved)
- - If you hate structure and will not use the coaching tools
Best for: People who want a comprehensive, clinician-led program and have commercial insurance.
Calibrate treats weight loss as a metabolic problem, not a willpower problem. Their One-Year Metabolic Reset combines FDA-approved GLP-1 medication with biweekly coaching sessions, a structured curriculum (food, sleep, exercise, emotional health), and required lab testing.
They guarantee 10% body weight loss in one year or your money back (minus assessment, meds, and labs). Their data shows earliest members achieved 15% average weight loss, and three-year data shows 19% maintained.
Verified Pricing (December 2025)
- Membership: $199/month (3-month minimum)
- Or paid upfront: ~$1,649/year
- Medication: Via insurance (~$25/mo after deductible)
Cancellation: 72-hour cancellation window.
Who should skip Calibrate:
- - If you do not have commercial insurance (they require it for medication access)
- - If you want compounded or cash-pay options for meds
- - If you want fast access—their insurance process can take 6-8 weeks
- - If you are 65+ (they only accept ages 18-64)
Best for: Cash-pay patients who want the lowest monthly cost with month-to-month flexibility.
MEDVi offers compounded semaglutide starting at $179/month all-inclusive (consultation, medication, shipping). No insurance, no prior auth hassle, no long-term commitment. They work with 503A and 503B compounding pharmacies.
Verified Pricing (December 2025)
- Semaglutide: $179-299/month (dose-dependent)
- Tirzepatide: $279-499/month (dose-dependent)
- All-inclusive (consult + meds + shipping)
Cancellation: Month-to-month. Cancel anytime before next billing cycle.
Who should skip MEDVi:
- - If you want brand-name medications only (Wegovy, Zepbound)
- - If you have good insurance coverage for GLP-1s—compounded is not covered
- - If you are uncomfortable with the regulatory uncertainty around compounded GLP-1s
Frequently Asked Questions
Clinical Sources and References
- Aronne LJ, et al. Tirzepatide Once Weekly for the Treatment of Obesity in People Without Diabetes Compared With Semaglutide. NEJM. 2025;393(1):26-36. [SURMOUNT-5 trial]
- Wharton S, et al. Oral semaglutide 25 mg in adults with overweight or obesity: the OASIS 4 trial. Lancet. 2025.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM. 2021;384(11):989-1002. [STEP 1 trial]
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM. 2022;387(3):205-216. [SURMOUNT-1 trial]
- FDA. Clarifies policies for compounders as national GLP-1 supply begins to stabilize. December 2024.
- FDA. Concerns with unapproved GLP-1 drugs used for weight loss. 2025.
- FDA. Approves first oral GLP-1 for chronic weight management. December 22, 2025.
About This Page
David Reynolds focuses on telehealth access, program transparency, and decoding fine print. He is not a clinician. This site publishes comparison content emphasizing clear pricing, clear cancellation policies, and citations to authoritative sources.
Editorial policy: We do not accept payment to change rankings. Some providers are affiliate partners; affiliate relationships do not determine placement. Content is updated when policies or pricing change.
Last reviewed: December 27, 2025. Pricing verified through provider websites.